

HY-130326 · 1 mg
MedChemExpress · Cat: HY-130326
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/rapta-c.html
Description
RAPTA-C Ru ?6-p-cymene Cl2 pta acts as an anti-cancer and anti-angiogenic agent. RAPTA-C exhibits anti-metastatic, anti-angiogenic, and anti-tumoral activities through protein and histone-deoxyribonucleic acid alterations. RAPTA-C exhibits cell growth inhibition by triggering G 2 /M phase arrest in cancer cells. RAPTA-C also enhances the levels of p53 and triggers the mitochondrial Apoptotic pathway, resulting in cytochrome C release and caspase-9 activation. RAPTA-C reduces the growth of tumors with the inhibition of angiogenesis in a ovarian carcinoma model.







